Springer Nature
Browse
13058_2021_1402_MOESM2_ESM.pdf (21.52 kB)

Additional file 2 of Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer

Download (21.52 kB)
journal contribution
posted on 2021-02-19, 05:31 authored by Kamila Kaminska, Nina Akrap, Johan Staaf, Carla L. Alves, Anna Ehinger, Anna Ebbesson, Ingrid Hedenfalk, Lukas Beumers, Srinivas Veerla, Katja Harbst, Sidse Ehmsen, Signe Borgquist, Åke Borg, Alejandro Pérez-Fidalgo, Henrik J. Ditzel, Ana Bosch, Gabriella Honeth
Additional file 2. Table showing patient characteristics for patient samples pre and post fulvestrant treatment.

Funding

Fru Berta Kamprads Stiftelse Crafoordska Stiftelsen Gunnar Nilssons Cancerstiftelse Kungliga Fysiografiska Sällskapet i Lund Percy Falks Stiftelse för Forskning Beträffande Prostata- och Bröstcancer Skånes universitetssjukhus ISREC Foundation

History

Usage metrics

    Breast Cancer Research

    Categories

    Keywords

    Metastatic breast cancerEndocrine treatment resistanceCell cycle inhibitorsFulvestrantCyclin E2

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC